Delivery Order SPE2DB24D8001-SPE2DB25FLAMW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,596.22 to Dakota Drug, Inc. on August 25, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets in quantities of 28 tablets. This firm fixed-price delivery order is scheduled for completion by August 26, 2025, with performance taking place in Anoka, Minnesota. The award utilized no set-aside designation and represents a straightforward pharmaceutical procurement from Dakota Drug, Inc., a self-certified small disadvantaged...
- This is a delivery order award to Dakota Drug, Inc., a self-certified small disadvantaged business, under the Defense Logistics Agency's (DLA) Troop Support Medical ECAT Generation V Program. The $1,468.56 firm fixed-price award is for the delivery of Junel FE 1.5 mg-30 mcg tablets to support U.S. Armed Forces medical operations. The award has an ultimate completion date of January 28, 2025. Dakota Drug, Inc. also holds a single-award Indefinite Delivery Contract (IDC) with the DLA, valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a small disadvantaged business. The contract, valued at $3,280.74, is for the supply of the pharmaceutical product JUNEL FE 1.5 MG-30 MCG TABLET 28S. The contract has a period of performance through May 24, 2024. Dakota Drug, Inc. is an experienced prime contractor that specializes in providing a wide range of pharmaceutical products, medical supplies,...
- This federal contract award, valued at $3,126.11, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Firm Fixed Price Delivery Order for the supply of JUNEL FE 1.5 MG-30 MCG TABLET 28S, a pharmaceutical product. The award is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop...
- The Defense Logistics Agency awarded a $2,125.75 delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Drospirenone-EE 3-0.02 mg tablets (28-count). The contract, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $11,449.26 firm fixed-price delivery order is for the supply of pharmaceutical products, specifically LO LOESTRIN FE 1-10 tablets, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order on August 27, 2025, for Drospirenone-EE 3-0.02 mg tablets (28-count packages) under a firm fixed-price contract valued at $1,724.18. The Defense Logistics Agency, an arm of the U.S. Department of Defense, issued this unrestricted award with an ultimate completion date of August 28, 2025. This delivery order is issued under Dakota Drug's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,003.71 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Premarin 0.625 mg tablets (100-count units). The contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, operates under a firm fixed-price delivery order structure with no set-aside designation. This award falls under Dakota Drug's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,177.72 delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Mirena 52 mg systems. The contract, issued on October 31, 2024, with an ultimate completion date of November 22, 2024, utilizes firm fixed pricing and carries no set-aside designation. This delivery order is executed under Dakota Drug's larger single-award Indefinite Delivery Contract (SPE2DB24D8001) valued at...
- This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBRBT, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc. The $1,643.04 delivery order contract is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. Dakota Drug, Inc. is a self-certified small disadvantaged business registered in SAM.gov, operating as a for-profit Subchapter S corporation. The company specializes in providing pharmaceutical products,...
- SPE2DB24D8001Indefinite Delivery Contract
- SPE2DB24D8001-SPE2DB25FLAMWDelivery Order
The Defense Logistics Agency awarded a $1,534.76 delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Junel FE 1 mg-20 mcg tablets (28-count packaging). The contract is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and was issued without a set-aside designation. Dakota Drug, Inc. is performing this work at its Anoka, Minnesota location as part of its broader role supplying pharmaceutical products and medical equipment to federal agencies. This delivery order falls under Dakota Drug, Inc.'s significant Indefinite Delivery Contract (SPE2DB24D8001) with the Defense Logistics Agency, valued at $999,999,999.00 and running through December 31, 2025. The parent contract is part of DLA Troop Support Medical's ECAT Generation V Program, which encompasses commercial medical equipment, accessories, consumables, and medical simulation equipment to support U.S. Armed Forces medical operations. Dakota Drug, Inc. has established itself as a critical vendor in the military medical supply chain, delivering a comprehensive range of pharmaceuticals and medical supplies including hormonal treatments, cardiovascular medications, diabetes management products, and vaccines to defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/23/25 |